MetLife Investment Management’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $962K | Buy |
56,576
+1,568
| +3% | +$26.7K | 0.01% | 1338 |
|
|
2025
Q1 | $1.07M | Buy |
55,008
+8,108
| +17% | +$158K | 0.01% | 1333 |
|
|
2024
Q4 | $1.16M | Buy |
46,900
+3,366
| +8% | +$83.5K | 0.01% | 1334 |
|
|
2024
Q3 | $1.07M | Hold |
43,534
| – | – | 0.01% | 1356 |
|
|
2024
Q2 | $1.02M | Buy |
43,534
+5,450
| +14% | +$128K | 0.01% | 1341 |
|
|
2024
Q1 | $1.26M | Hold |
38,084
| – | – | 0.01% | 1173 |
|
|
2023
Q4 | $1.04M | Buy |
38,084
+2,054
| +6% | +$55.9K | 0.01% | 1270 |
|
|
2023
Q3 | $867K | Hold |
36,030
| – | – | 0.01% | 1307 |
|
|
2023
Q2 | $1.15M | Buy |
36,030
+2,640
| +8% | +$84.3K | 0.01% | 1192 |
|
|
2023
Q1 | $1.02M | Hold |
33,390
| – | – | 0.01% | 1215 |
|
|
2022
Q4 | $1.31M | Sell |
33,390
-989
| -3% | -$38.7K | 0.01% | 1081 |
|
|
2022
Q3 | $1.64M | Buy |
34,379
+1,325
| +4% | +$63.1K | 0.01% | 965 |
|
|
2022
Q2 | $1.28M | Buy |
33,054
+5,925
| +22% | +$229K | 0.01% | 1090 |
|
|
2022
Q1 | $1.55M | Buy |
27,129
+9,829
| +57% | +$563K | 0.01% | 1099 |
|
|
2021
Q4 | $1.38M | Hold |
17,300
| – | – | 0.01% | 997 |
|
|
2021
Q3 | $1.51M | Buy |
17,300
+497
| +3% | +$43.2K | 0.01% | 960 |
|
|
2021
Q2 | $2.16M | Buy |
16,803
+1,431
| +9% | +$184K | 0.02% | 842 |
|
|
2021
Q1 | $1.23M | Hold |
15,372
| – | – | 0.01% | 1056 |
|
|
2020
Q4 | $1.25M | Hold |
15,372
| – | – | 0.01% | 1029 |
|
|
2020
Q3 | $378K | Buy |
15,372
+8,751
| +132% | +$215K | ﹤0.01% | 1516 |
|
|
2020
Q2 | $185K | Hold |
6,621
| – | – | ﹤0.01% | 1956 |
|
|
2020
Q1 | $119K | Buy |
+6,621
| New | +$119K | ﹤0.01% | 1982 |
|